Longevity · Launchpad care path

NAD+ — cellular energy support on the partner care path.

NAD+ (NAD) is on the OpenLoop Launchpad contract. Livozo is the brand and marketing site; after a qualify CTA, OpenLoop hosts intake and their clinicians decide whether NAD+ is appropriate. Compounded NAD+ is not FDA-approved. Care is not live until Launchpad is wired.

At a glance

What this page is built to clarify.

Care-path focus

On the Launchpad contract

Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo.

Care-path focus

Partner clinician review

Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo.

Care-path focus

Licensed sourcing only

Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo.

Clinical context

How to read this page.

These pages describe possible pathways, not a promise that any medication will be prescribed, shipped this week, or available in any state today. Livozo does not employ the prescriber.

Compounded NAD+ is not FDA-approved. Suitability, route, and dose are partner clinician decisions. FDA has issued alerts about sterile injectables generally — sourcing and pharmacy quality matter.
  • Low energy or fatigue
  • Focus and recovery goals
  • Healthy-aging interest
  • Interest in supervised wellness injectables

Partner model

What the partner path can include.

When Launchpad is wired

  • Partner-hosted medical and medication intake
  • OpenLoop clinician review of suitability
  • Dosing and administration guidance from the partner if prescribed
  • Partner portal follow-up — Livozo does not run the clinic

Potential options

  • Compounded NAD+ when a partner clinician prescribes
  • B12 is a separate Launchpad path when appropriate

Exact medication, formulation, quantity, refill timing, and pharmacy routing depend on the clinical partner, applicable law, and clinical appropriateness. OpenLoop's licensed 503A network — not an exclusive Red Rock claim — fulfills partner prescriptions if written.

Next step

See if you qualify — partner intake, not a live clinic.

This is a Launchpad care path, not live clinician care. A “see if I qualify” step is meant to hand off to OpenLoop white-label intake when that contract is wired. Until then, eligibility is informational. No prescription, charge, or shipment happens from this site.

See if I qualify